AAKP is supporting a research initiative with Relavo, a medical device company aiming to make peritoneal dialysis safer and more accessible by reducing the risk of peritonitis, which hospitalizes 15% of PD patients annually. Relavo is a recent winner of the KidneyX Innovation Accelerator Phase 2: Redesign Dialysis Competition, and of the KidneyX Patient Innovator Challenge. AAKP and Relavo are seeking patients and caregivers with CCPD experience that are over 18, currently live in the US, and read/understand English, to participate in an online survey. The results will be used to ensure that a Relavo device, the PeritoneX, addresses what matters most to patients and caregivers. Learn more about PeritoneX, which disinfects CCPD tubing during treatment set-up, at https://relavomedical.com/. Find the survey at https://www.surveygizmo.com/s3/5787206/Relavo-Device-Survey.
